In last trading session, Guardant Health Inc (NASDAQ:GH) saw 2.31 million shares changing hands with its beta currently measuring 1.49. Company’s recent per share price level of $49.00 trading at $0.73 or 1.51% at ring of the bell on the day assigns it a market valuation of $6.05B. That closing price of GH’s stock is at a discount of -3.86% from its 52-week high price of $50.89 and is indicating a premium of 67.73% from its 52-week low price of $15.81.
For Guardant Health Inc (GH), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.44. Splitting up the data highlights that, out of 13 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 13 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.5 in the current quarter.
Guardant Health Inc (NASDAQ:GH) trade information
Upright in the green during last session for gaining 1.51%, in the last five days GH remained trading in the green while hitting it’s week-highest on Tuesday, 02/18/25 when the stock touched $49.00 price level, adding 1.8% to its value on the day. Guardant Health Inc’s shares saw a change of 60.39% in year-to-date performance and have moved 12.39% in past 5-day. Guardant Health Inc (NASDAQ:GH) showed a performance of 33.66% in past 30-days.
Wall Street analysts have assigned a consensus price target of 40 to the stock, which implies a fall of -22.5% to its current value. Analysts have been projecting 40 as a low price target for the stock while placing it at a high target of 40. It follows that stock’s current price would jump 18.37% in reaching the projected high whereas dropping to the targeted low would mean a gain of 18.37% for stock’s current value.
Guardant Health Inc (GH) estimates and forecasts
This year revenue growth is estimated to rise 29.28% from the last financial year’s standing.
18 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 192.5M for the same. And 17 analysts are in estimates of company making revenue of 190.4M in the next quarter. Company posted 155.05M and 168.49M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -8.88% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 20.26% while estimates for its earnings growth in next 5 years are of 16.87%.
Guardant Health Inc (NASDAQ:GH)’s Major holders
VANGUARD GROUP INC is the top institutional holder at GH for having 11.64 million shares of worth $336.07 million. And as of 2024-06-30, it was holding 9.5609 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 11.24 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.2332 of outstanding shares, having a total worth of $324.55 million.
On the other hand, Vanguard Specialized-Health Care Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Oct 31, 2024 , the former fund manager was holding 8.33 shares of worth $408.17 million or 6.74% of the total outstanding shares. The later fund manager was in possession of 3.67 shares on Sep 30, 2024 , making its stake of worth around $179.64 million in the company or a holder of 2.97% of company’s stock.
